GSK Plc ADR
GSK Plc ADR (GSK) Implied Volatility Current
GSK implied volatility is 25%. IV Rank is 16%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking GSK implied volatility helps you identify when options premiums on GSK Plc ADR are historically cheap or expensive, and where the best trades are hiding. GSK Plc ADR implied volatility reflects the market's expectation of future price movement: when GSK IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor GSK Plc ADR's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For GSK, tracking metrics like GSK IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on GSK signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections.
It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where GSK implied volatility sits today versus where it has been. Our scanner ranks GSK Plc ADR implied volatility against its historical range, surfaces extremes in GSK IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether GSK Plc ADR IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 22, 2026
Trade options with IV on your side
Track GSK IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→